Wedbush Upgrades Harpoon Therapeutics (HARP) to Outperform

May 16, 2022 6:35 AM EDT
Get Alerts HARP Hot Sheet
Price: $23.01 --0%

Rating Summary:
    5 Buy, 7 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE

Wedbush analyst Robert Driscoll upgraded Harpoon Therapeutics (NASDAQ: HARP) from Neutral to Outperform with a price target of $7.00 (from $5.00).


For an analyst ratings summary and ratings history on Harpoon Therapeutics click here. For more ratings news on Harpoon Therapeutics click here.


Shares of Harpoon Therapeutics closed at $2.00 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades